Medical articles of Prostate cancer

Here, esteemed consultant urologist, Mr Tom Leslie, discusses raised PSA levels in expert detail, including what they typically imply for men.

Abiraterone with prednisolone has emerged as an important treatment option for selected men with high-risk non-metastatic prostate cancer, helping to improve long-term outcomes when used alongside sta...

Here, highly esteemed consultant clinical oncologist, Dr Gurdip Azad, shares her expert insights regarding seminal vesicle involvement for prostate cancer.

Prostate cancer is the most commonly diagnosed cancer in men in the UK, affecting more than 52,000 men every year. Despite this, a significant proportion of cases are identified at a later stage, when...

On hand to discuss prostate cancer at length and in expert detail is highly distinguished consultant urologist and robotic surgeon, Mr Murthy Kusuma.

Prostate cancer is one of the most common cancers affecting men in the UK, yet its early signs can often be subtle or mistaken for benign conditions. Recognising potential prostate cancer symptoms and...

Prostate cancer is the most commonly diagnosed cancer in men in the UK, affecting more than 52,000 men every year. However, many men go undiagnosed until the disease is quite advanced and this becomes...

Here to discuss the symptoms that typically appear in men once initial stages of prostate cancer have passed is esteemed consultant urologist and robotic surgeon, Mr Biral Patel.

Newer diagnostic tools, such as the EPI Switch PSE test, have been developed to improve accuracy in assessing prostate cancer risk and help guide decision-making. These tests aim to reduce unnecessary...

In this article here, leading consultant urological and robotic surgeon, Mr Torath Ameen, describes the importance of PSA testing for men who are worried about developing prostate cancer.